Minesh P Mehta MD FASTRO
Central Nervous System Cancer, Thoracic Cancer
Professor and Chair, Radiation Oncology, School of Medicine, Florida International University
8900 N Kendall Dr# MiamiMiami, FL 33176
Fax+1 305-279-7778
Overview of Dr. Mehta
Dr. Minesh Mehta is a Miami-based radiation oncologist specializing in cancers of the central nervous system and thoracic region. He completed his residency at the University of Wisconsin Hospitals and Clinics after earning his medical degree from the University of Zambia. Dr. Mehta currently serves as Professor and Chair of Radiation Oncology at Florida International University Herbert Wertheim College of Medicine. His clinical expertise includes neuro-oncology, lung cancer, gliomas, stereotactic and functional surgery, and stereotactic radiosurgery. He has authored several publications and is involved in clinical trials related to radiotherapy and cancer treatment. Dr. Mehta has been recognized by Castle Connolly as one of America's Top Doctors and Top Doctors for Cancer.
Education & Training
University of Wisconsin Hospitals and ClinicsResidency, Radiation Oncology, 1984 - 1988
University of Zambia, School of MedClass of 1981
Certifications & Licensure
FL State Medical License 2015 - 2028
MD State Medical License 2012 - 2027
WI State Medical License 1987 - 2027
CA State Medical License 2011 - 2026
IL State Medical License 1985 - 2026
OH State Medical License 2010 - 2026
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2010, 2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2009, 2013
- Top Doctors:Baltimore Area Castle Connolly, 2012
Clinical Trials
- Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma Start of enrollment: 1999 Feb 02
- Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma
- Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer Start of enrollment: 2004 Oct 06
Publications & Presentations
PubMed
- Stereotactic radiosurgery using a self-shielded gyroscopic radiosurgery system for meningiomas: technical aspects and dosimetric results.Yongsook C Lee, Rupesh Kotecha, Robert H Press, Noah S Kalman, Matthew D Hall
Radiation Oncology. 2026-07-21 - 1 citationsTreatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.Tulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, Eudocia Q Lee, Isabel Arrillaga-Romany
Journal of Clinical Oncology. 2026-07-20 - Global Consensus on the Management of Primary Localized Chordoma.Stefano Radaelli, Anna M Frezza, Piero Fossati, Giacomo G Baldi, Toru Akiyama
JAMA Oncology. 2026-07-09
Journal Articles
- Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported OutcomesKevin S Roof, Paul D Brown, Samuel T Chao, William A Hall, Minesh P Mehta, Benjamin Movsas, Jeffrey S Wefel, Neurosurgery
- Multi-Institutional External Validation of a Novel Glioblastoma Prognostic Nomogram Incorporating MGMT MethylationShahed N Badiyan, Minesh P Mehta, Yuan James Rao, Liam T Kane, Jason K Molitoris, Jiayi Huang, Journal of Neuro-Oncology
Press Mentions
NRG Oncology Trial Reveals Enhanced Survival in Glioblastoma Patients Treated with Proton Therapy, Advances to Phase IIISeptember 30th, 2025- Proton Therapy Dose Escalation May Improve Outcomes for Glioblastoma PatientsSeptember 29th, 2025
- Leadership Announced for New Clinical Departments at FIU MedicineJuly 21st, 2025
Grant Support
- Nabtc (Ucsf Project Leader) U Of WisconsinNational Cancer Institute1998–2008
- Phase II Trial Of EMD 121974 For Recurrent GlioblastomaNational Center For Research Resources2007
- Phase II Study Of Xrt + Low-Dose Temozolomide Followed By Temozolomide + CPT-11National Center For Research Resources2006–2007
- Phase I/II Study Of OSI-774 And CCI-779 In Recurrent Malignant GliomaNational Center For Research Resources2006–2007
- Phase I/II Trial Of CPT-11 And Temozolomide In Recurrent Malignant GliomaNational Center For Research Resources2004–2006
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS California PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Health Care PPO PlatinumCoventry Missouri - HMO/POS
First Health PPO
Great West PPO
HealthLink PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
